- Home
- ACXP vs CELZ Comparison
ACXP vs CELZ Comparison
Compare ACXP & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- CELZ
- Stock Information
- Founded
- ACXP 2017
- CELZ 1998
- Country
- ACXP United States
- CELZ United States
- Employees
- ACXP N/A
- CELZ N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- ACXP Health Care
- CELZ Health Care
- Exchange
- ACXP Nasdaq
- CELZ Nasdaq
- Market Cap
- ACXP 8.4M
- CELZ 7.4M
- IPO Year
- ACXP 2021
- CELZ N/A
- Fundamental
- Price
- ACXP $0.31
- CELZ $2.87
- Analyst Decision
- ACXP Strong Buy
- CELZ
- Analyst Count
- ACXP 2
- CELZ 0
- Target Price
- ACXP $10.00
- CELZ N/A
- AVG Volume (30 Days)
- ACXP 920.6K
- CELZ 236.3K
- Earning Date
- ACXP 08-12-2025
- CELZ 08-12-2025
- Dividend Yield
- ACXP N/A
- CELZ N/A
- EPS Growth
- ACXP N/A
- CELZ N/A
- EPS
- ACXP N/A
- CELZ N/A
- Revenue
- ACXP N/A
- CELZ $14,000.00
- Revenue This Year
- ACXP N/A
- CELZ N/A
- Revenue Next Year
- ACXP N/A
- CELZ N/A
- P/E Ratio
- ACXP N/A
- CELZ N/A
- Revenue Growth
- ACXP N/A
- CELZ 55.56
- 52 Week Low
- ACXP $0.29
- CELZ $1.69
- 52 Week High
- ACXP $2.39
- CELZ $6.90
- Technical
- Relative Strength Index (RSI)
- ACXP 33.75
- CELZ 56.53
- Support Level
- ACXP $0.30
- CELZ $2.51
- Resistance Level
- ACXP $0.50
- CELZ $2.85
- Average True Range (ATR)
- ACXP 0.05
- CELZ 0.19
- MACD
- ACXP -0.02
- CELZ -0.01
- Stochastic Oscillator
- ACXP 7.86
- CELZ 94.41
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.